Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
- PMID: 32128276
- PMCID: PMC7018717
- DOI: 10.1038/s41413-020-0084-5
Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
Erratum in
-
Correction: Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study.Bone Res. 2020 Sep 21;8:34. doi: 10.1038/s41413-020-00113-1. eCollection 2020. Bone Res. 2020. PMID: 32983581 Free PMC article.
Abstract
The most severe sequelae after rehabilitation from SARS are femoral head necrosis and pulmonary fibrosis. We performed a 15-year follow-up on the lung and bone conditions of SARS patients. We evaluated the recovery from lung damage and femoral head necrosis in an observational cohort study of SARS patients using pulmonary CT scans, hip joint MRI examinations, pulmonary function tests and hip joint function questionnaires. Eighty medical staff contracted SARS in 2003. Two patients died of SARS, and 78 were enrolled in this study from August 2003 to March 2018. Seventy-one patients completed the 15-year follow-up. The percentage of pulmonary lesions on CT scans diminished from 2003 (9.40 ± 7.83)% to 2004 (3.20 ± 4.78)% (P < 0.001) and remained stable thereafter until 2018 (4.60 ± 6.37)%. Between 2006 and 2018, the proportion of patients with interstitial changes who had improved pulmonary function was lower than that of patients without lesions, as demonstrated by the one-second ratio (FEV1/FVC%, t = 2.21, P = 0.04) and mid-flow of maximum expiration (FEF25%-75%, t = 2.76, P = 0.01). The volume of femoral head necrosis decreased significantly from 2003 (38.83 ± 21.01)% to 2005 (30.38 ± 20.23)% (P = 0.000 2), then declined slowly from 2005 to 2013 (28.99 ± 20.59)% and plateaued until 2018 (25.52 ± 15.51)%. Pulmonary interstitial damage and functional decline caused by SARS mostly recovered, with a greater extent of recovery within 2 years after rehabilitation. Femoral head necrosis induced by large doses of steroid pulse therapy in SARS patients was not progressive and was partially reversible.
Keywords: Bone; Calcium and phosphate metabolic disorders.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare no competing interests.
Figures



Comment in
-
Post-Acute Sequelae of COVID-19 Pneumonia: Six-month Chest CT Follow-up.Radiology. 2021 Nov;301(2):E396-E405. doi: 10.1148/radiol.2021210834. Epub 2021 Jul 27. Radiology. 2021. PMID: 34313468 Free PMC article.
Similar articles
-
Multiomic characterisation of the long-term sequelae of SARS survivors: a clinical observational study.EClinicalMedicine. 2023 Apr;58:101884. doi: 10.1016/j.eclinm.2023.101884. Epub 2023 Feb 27. EClinicalMedicine. 2023. PMID: 36873427 Free PMC article.
-
[Changes in pulmonary function in SARS patients during the three-year convalescent period].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Sep;19(9):536-8. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007. PMID: 17767822 Chinese.
-
1-year pulmonary function and health status in survivors of severe acute respiratory syndrome.Chest. 2005 Sep;128(3):1393-400. doi: 10.1378/chest.128.3.1393. Chest. 2005. PMID: 16162734 Free PMC article.
-
Follow-Up Analysis of Pulmonary Function, Exercise Capacity, Radiological Changes, and Quality of Life Two Months after Recovery from SARS-CoV-2 Pneumonia.Medicina (Kaunas). 2021 Jun 3;57(6):568. doi: 10.3390/medicina57060568. Medicina (Kaunas). 2021. PMID: 34204878 Free PMC article.
-
Correlation of high-resolution CT, symptoms, and pulmonary function in patients during recovery from severe acute respiratory syndrome.Chest. 2004 Jul;126(1):149-58. doi: 10.1378/chest.126.1.149. Chest. 2004. PMID: 15249456 Free PMC article.
Cited by
-
COVID-19: Patient care after discharge from the Intensive Care Unit.Int J Clin Pract. 2021 Sep;75(9):e14270. doi: 10.1111/ijcp.14270. Epub 2021 Jul 5. Int J Clin Pract. 2021. PMID: 34080267 Free PMC article.
-
Citation Network Analysis of the Novel Coronavirus Disease 2019 (COVID-19).Int J Environ Res Public Health. 2020 Oct 21;17(20):7690. doi: 10.3390/ijerph17207690. Int J Environ Res Public Health. 2020. PMID: 33096796 Free PMC article.
-
A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19.ERJ Open Res. 2023 Mar 13;9(2):00575-2022. doi: 10.1183/23120541.00575-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 36915802 Free PMC article.
-
How COVID-19 interacts with interstitial lung disease.Breathe (Sheff). 2022 Mar;18(1):210158. doi: 10.1183/20734735.0158-2021. Epub 2021 Mar 8. Breathe (Sheff). 2022. PMID: 35284020 Free PMC article. Review.
-
Six-month Morbidity and Mortality in Patients after Recovery from COVID-19.Indian J Crit Care Med. 2022 Nov;26(11):1179-1183. doi: 10.5005/jp-journals-10071-24347. Indian J Crit Care Med. 2022. PMID: 36873598 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous